SAGE Therapeutics Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest SAGE Therapeutics' careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

**Manager, Regulatory Affairs (Advertising & Promotion)** **General Scope and Summary** SAGE Therapeutics is searching for a creative, resourceful, strategic thinker for an important role that is responsible for overseeing the regula...
Posted: February 15, 2019, 4:00 pm
**General Scope and Summary** SAGE Therapeutics requires a creative, resourceful, integrative thinker to play a critical cross-functional role within Clinical Development. The ideal candidate will oversee clinical trials (pre-IND through Phase ...
Posted: February 14, 2019, 8:20 am
**General Scope and Summary** Sage Therapeutics is searching for a creative, resourceful, integrative thinker for an important role that is responsible for complete business ownership of Regional Trade Accounts. This person will implement t...
Posted: February 14, 2019, 8:20 am
**General Scope and Summary** Sage Therapeutics is searching for a creative, resourceful, integrative thinker for an important role that is responsible for complete business ownership of Regional Trade Accounts. This person will implement t...
Posted: February 14, 2019, 8:20 am
**General Scope and Summary** SAGE Therapeutics is seeking a creative, self-driven, and collaborative clinical compliance leader to contribute to a developing role within Clinical Operations and Development at Sage Therapeutics. The Associ...
Posted: February 13, 2019, 8:25 am

Viewing page 1 of 7|Next Page

  Newsfeed | Subscribe  

Sage Therapeutics, Inc. SAGE, +1.80% a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today reported business highli...
Posted: February 19, 2019, 3:29 am
Hoffmann-La Roche Ltd., Marinus Pharmaceuticals, Inc., MI.TO. Technology S.r.L., Neuren Pharmaceuticals Limited, Ovid Therapeutics Inc., Sage Therapeutics, Inc., Zynerba Pharmaceuticals, Inc. Initiall...
Posted: February 15, 2019, 10:24 am
Up 0.8% at $159.30, at last check, drug name SAGE Therapeutics Inc (NASDAQ:SAGE) is scheduled to report fourth-quarter earnings before the market opens on Tuesday, Feb. 19. Below, we will take a look ...
Posted: February 15, 2019, 10:12 am
Baker Bros. Advisors LP, a hedge fund known for making big biotechnology bets, looks to have relinquished its stake in Sage Therapeutics Inc. leading up the drugmaker’s slam-dunk depression study. Bak...
Posted: February 14, 2019, 7:38 am
After sliding 41.8% in 2018, shares of Sage Therapeutics (NASDAQ: SAGE) jumped nearly 49% last month, according to data from S&P Global Market Intelligence. The sudden leap came after the company ...
Posted: February 10, 2019, 5:44 pm

Viewing page 1 of 3|Next Page